Mapfre

COVID-19 fragility

26/03/20 -"The reduction in our target price was driven by lower earnings for 2020-22 and the increase in the discount, attributed to P/Book, P/E and dividend yield relative to its peers, from 20% to 40%. This ..."

PDF page sample
Pages
52
Language
English
Published on
26/03/20
Download
You may also be interested by these reports :
06/10/26
The insurance sector’s outperformance has continued in recent months, driven primarily by robust earnings growth, although valuation multiples have ...
30/09/26
Should one chase the 5.7% yield that Real Estate dangles? Or forget yield altogether, buy Semiconductors and pray? Below is the pecking order of ...
23/09/26
Helvetia Baloise has released a strong set of 1H26 results. While the top line remained weak, underlying earnings came in ahead of expectations. At ...
15/09/26
AXA has unveiled its strategic plan for the 2027-29 period. While the targets did not include any major surprises, management’s reaffirmed confidence ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO